Clinical trial

Travoprost Intraocular Implant + iStent Infinite

NCT06066645

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2023-09-14

PhasePHASE4

Study timeline

Study start (actual)2023-09-14Date precision: day

Registry last updated2026-06-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Glaucoma, Open-Angleunresolved

Interventions

Travoprost Intraocular ImplantDRUG

iStent infiniteDEVICE

Sham procedureOTHER

Sponsors & collaborators

Glaukos Corporationlead sponsor

Mapped research locations

Oklahoma CityOklahoma, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06066645 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.